Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial:

Lata Jayaram, Alain C. Vandal, Catherina L. Chang, Chris Lewis, Cecilia Tong, Christine Tuffery, Jill Bell, Wendy Fergusson, Gene Jeon, David Milne, Stuart Jones, Noel Karalus, Sandra Hotu and Conroy Wong

9 June, 2022

NZ Respiratory Research Review Issue 203

Cardiovascular Events During and After Bronchiectasis Exacerbations and Long-term Mortality:

Raúl Méndez MD, PhD, Laura Feced MD, Victoria Alcaraz-Serrano PhD, Paula González-Jiménez MD, Leyre Bouzas MD, Ricardo Alonso MD, Luis Martínez-Dolz MD, PhD, David Hervás PhD, Laia Fernández-Barat PhD, Antoni Torres MD, PhD, Rosario Menéndez MD, PhD

1 March, 2022

NZ Respiratory Research Review Issue 203

Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial:

Pallavi Bedi, Manjit K. Cartlidge, Yang Zhang, Kim Turnbull, Samantha Donaldson, Andrea Clarke, Jane Crowe, Kadiga Campbell, Catriona Graham, Ruzanna Franguylan, Adriano G. Rossi, Adam T. Hill

16 December, 2021

NZ Respiratory Research Review Issue 203

Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study:

Holly R Keir, BSc Amelia Shoemark, PhD Alison J Dicker, PhD Lidia Perea, MSc Jennifer Pollock Yan Hui Giam, BSc et al.

17 February, 2021

NZ Respiratory Research Review Issue 191

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis:

James D. Chalmers, M.B., Ch.B., Ph.D., Charles S. Haworth, M.B., Ch.B., M.D., Mark L. Metersky, M.D., Michael R. Loebinger, B.M., B.Ch., Ph.D., Francesco Blasi, M.D., Ph.D., Oriol Sibila, M.D., Ph.D., Anne E. O’Donnell, M.D., Eugene J. Sullivan, M.D., Kevin C. Mange, M.D., M.S.C.E., Carlos Fernandez, M.D., M.P.H., Jun Zou, Ph.D., and Charles L. Daley, M.D. for the WILLOW Investigators*

26 November, 2020

NZ Respiratory Research Review Issue 179

Airway Clearance Techniques in Bronchiectasis:

Ashwin Basavaraj, MD Radmila Choate, PhD, MPH Doreen Addrizzo-Harris, MD Byron Thomashow, MD Gregory Tino, MD Kevin L. Winthrop, MD, MPH et al.

2 July, 2020

Respiratory Research Review Issue 179

Cost of hospitalization for bronchiectasis exacerbation in children:

Vikas Goyal,Steven M. McPhail,Frank Hurley,Keith Grimwood,Julie M. Marchant,I. Brent Masters,Anne B. Chang

1 May, 2020

NZ Respiratory Research Review Issue 191

Association between physical activity and risk of hospitalisation in bronchiectasis:

Victoria Alcaraz-Serrano, Elena Gimeno-Santos, Giulia Scioscia, Albert Gabarrús, Adria Navarro, Beatriz Herrero-Cortina, Rosanel Amaro, Laia Fernández-Barat, Antoni Torres

3 March, 2020

Respiratory Research Review Issue 179

Improving outcomes for children with bronchiectasis and preventing it altogether:

Byrnes, C.

6 November, 2015

Presentation to Respiratory Conference New Zealand November 2015.

The impact of respiratory disease in New Zealand: 2014 update:

Telfar Barnard, L., Baker, M., Pierse, N., & Zhang, J.

4 April, 2015

This report covers six respiratory disease indicators: asthma, bronchiectasis, childhood bronchiolitis and pneumonia, chronic obstructive pulmonary disease (COPD), and total respiratory disease.